-
公开(公告)号:EP4422650A1
公开(公告)日:2024-09-04
申请号:EP22888260.1
申请日:2022-10-28
CPC分类号: A61K35/12 , A61K9/5036 , A61K45/06
-
公开(公告)号:EP4351520A1
公开(公告)日:2024-04-17
申请号:EP22820961.5
申请日:2022-06-08
申请人: CYTODIGM, INC.
发明人: WU, Bin
CPC分类号: A61P1/00 , A61K9/19 , A61K9/5031 , A61K9/5153 , A61K9/5146 , A61K9/5192 , A61K9/5089 , A61K31/7105
-
公开(公告)号:EP4309643A3
公开(公告)日:2024-04-10
申请号:EP23194097.4
申请日:2015-06-22
发明人: SOANE, David S.
摘要: The invention encompasses formulations and methods for the production thereof that permit the delivery of concentrated protein solutions. The inventive methods can yield a lower viscosity liquid formulation or a higher concentration of therapeutic or nontherapeutic proteins in the liquid formulation, as compared to traditional protein solutions.
-
公开(公告)号:EP4306164A3
公开(公告)日:2024-03-20
申请号:EP23204861.1
申请日:2011-08-23
发明人: DEAVER, Daniel. , TODTENKOPF, Mark.
IPC分类号: A01N43/42 , A61K31/44 , A61P3/04 , A61K31/485
摘要: The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.
-
45.
公开(公告)号:EP3636800B1
公开(公告)日:2024-03-20
申请号:EP19213692.7
申请日:2017-09-22
-
公开(公告)号:EP4299681A3
公开(公告)日:2024-02-14
申请号:EP23211023.9
申请日:2020-08-10
申请人: The Boeing Company
摘要: A crystalline titanium and magnesium compound having an X-ray diffraction pattern having interplanar spacing ( d -spacing) values at about 5.94, 3.10, 2.97, 2.10, 1.98, 1.82, and 1.74 ± 0.1 angstroms may be used in protective coatings for metal or metal alloy substrates. The coatings exhibit excellent corrosion resistances and provide corrosion protection equal to or better than typical non-chromate coatings.
-
公开(公告)号:EP4306523A2
公开(公告)日:2024-01-17
申请号:EP23188546.8
申请日:2019-09-05
发明人: YANG, Lihu
IPC分类号: C07D471/04
摘要: Provided herein are imidazoquinoline derivatives, or pharmaceutically acceptable salts thereof, that are agonists of toll-like receptors 7 and 8 (TLR7/8). Also provided herein are compositions and pharmaceutical compositions comprising the imidazoquinoline derivatives, or pharmaceutically acceptable salts thereof, provided herein. Also provided herein are methods of use of the imidazoquinoline derivatives, or pharmaceutically acceptable salts thereof, provided herein to treat various diseases, such as viral, cancer, and allergic diseases, in a subject in need thereof by administering a therapeutically effective amount of the imidazoquinoline derivative, or pharmaceutically acceptable salt thereof, to the subject.
-
公开(公告)号:EP4306164A2
公开(公告)日:2024-01-17
申请号:EP23204861.1
申请日:2011-08-23
发明人: DEAVER, Daniel. , TODTENKOPF, Mark.
IPC分类号: A61P3/04
摘要: The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.
-
49.
公开(公告)号:EP4267577A1
公开(公告)日:2023-11-01
申请号:EP21912180.3
申请日:2021-12-22
发明人: DENER, Jeffrey Mark , HUNT, Hazel Joan , LEMONS, Travis , REID, Gary , GARREC, Kilian , STEPHENS, Thomas C. , YAMAGATA, Adam Daisuke Gammack , LU, Yunguo
IPC分类号: C07D471/04 , A61K31/444 , A61P1/16 , A61P25/18
-
公开(公告)号:EP3446565B1
公开(公告)日:2023-11-01
申请号:EP18198977.3
申请日:2011-08-23
发明人: DEAVER, Daniel , TODTENKOPF, Mark
IPC分类号: A61K31/439 , A61K31/551 , A61P3/04
-
-
-
-
-
-
-
-
-